Prisca Boisguérin - Professor, University of Montpellier, INSERM, CNRS

Prisca Boisguérin - Professor, University of Montpellier, INSERM, CNRS

🎙 Prisca Boisguérin 👥 1K 📅 March 9, 2026 ⏱ 34 min 👁 34 📄 original study 🧭 2026-08-16
Available in: English (current) Français

Keywords

CPPnanoparticlesmyocardial infarctioncystic fibrosissiRNA

Summary

Prisca Boisguérin, a professor at the University of Montpellier, presents her research on cell-penetrating peptides (CPPs) and their applications in pharmacology. She begins by describing her early work in Berlin, where she used spot synthesis to create peptide libraries and identified CPPs with varying internalization efficiencies. Moving to Montpellier, she focused on acute myocardial infarction, developing a peptide that blocks the interaction between Daxx and Fas receptors, thereby reducing apoptosis and infarct size in a mouse model. This peptide also improved cardiac function and reduced fibrosis over six months. She then discusses peptide-based nanoparticles formed by self-assembly of the amphipathic peptide VAP with nucleic acids. These nanoparticles, around 80 nm in size, internalize via direct translocation and can be functionalized with PEG or targeting sequences. Applications include gene knockdown in zebrafish and mitochondrial delivery. In cystic fibrosis, she uses target site blockers (TSBs) to prevent miRNA-mediated degradation of CFTR mRNA, and encapsulates them in nanoparticles to improve delivery and reduce off-target effects. This approach increased CFTR activity by 80% in patient-derived bronchial epithelial cells and showed improved biodistribution. She concludes by mentioning two startups aimed at translating these findings into clinical therapies.

192 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the development of CPP-based therapeutics, with a strong emphasis on translational research. The argumentation is solid, supported by experimental data from various in vitro and in vivo models, including mouse models of myocardial infarction and patient-derived cells for cystic fibrosis. The speaker clearly explains the rationale behind each step, from peptide design to nanoparticle formulation, and addresses potential limitations such as the need for PEGylation to avoid protein corona effects. The discussion of alternative internalization mechanisms and the use of inhibitors and knockout cell lines strengthens the scientific rigor. However, some claims, such as the long-term benefits in mice, are presented without detailed statistical analysis, and the lack of published references in the description limits immediate verification.

Scientific Rigor, Source Quality, Title Accuracy

The talk is scientifically rigorous, with a clear methodology and presentation of original data. The speaker cites collaborations with other researchers and institutions, but no specific sources are listed in the video description. The title accurately reflects the content, as it introduces the speaker and her research focus. The presentation is well-structured, moving from basic peptide chemistry to clinical applications. However, the absence of references in the description makes it difficult to verify the claims independently. The speaker also mentions a startup and ongoing clinical trials, but these are not detailed. Overall, the scientific quality is high, but the lack of accessible sources slightly reduces the overall reliability.

246 words

Title / Content Match

The title accurately reflects the content, as it introduces the speaker and her research on cell-penetrating peptides.

Quality & Reliability

8/10

The presentation is based on original research, with detailed experimental data and references to collaborations. However, the video is a conference talk without peer-reviewed references provided in the description, and some claims are not fully detailed.

Key Moments

Contribution & Novelties

The talk presents novel applications of cell-penetrating peptides in cardiovascular and genetic diseases, with a focus on translational potential. The use of VAP-based nanoparticles for targeted delivery of nucleic acids is innovative, and the demonstration of direct translocation as the internalization mechanism adds to the understanding of CPP behavior. The work on cystic fibrosis using TSBs encapsulated in nanoparticles is particularly promising, showing improved efficacy and reduced off-target effects.

Pour aller plus loin :

107 words

Radar Profile

The radar profile shows high scores in information quantity and quality, reflecting the dense content and experimental evidence. The technical level is moderate, suitable for a specialized audience. The overall reliability is good, but the lack of cited sources in the description slightly lowers the score.

Reliability 7/10